1. Home
  2. SYNX vs ADIL Comparison

SYNX vs ADIL Comparison

Compare SYNX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

HOLD

Current Price

$0.98

Market Cap

6.8M

Sector

N/A

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$6.35

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYNX
ADIL
Founded
2005
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
7.3M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
SYNX
ADIL
Price
$0.98
$6.35
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$37.50
AVG Volume (30 Days)
26.8K
73.5K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$32.35
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.13
52 Week High
$2.15
$5.94

Technical Indicators

Market Signals
Indicator
SYNX
ADIL
Relative Strength Index (RSI) 39.61 78.62
Support Level $0.92 $1.63
Resistance Level $1.10 N/A
Average True Range (ATR) 0.04 0.60
MACD -0.00 0.19
Stochastic Oscillator 28.57 100.00

Price Performance

Historical Comparison
SYNX
ADIL

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sells push-to-talk devices, communication controllers, and communication device cables and connectors. Geographically, it generates the majority of its revenue from Israel.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Share on Social Networks: